Efficacy and Safety of Tocilizumab for TAO
NCT06087731
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
For some personal reasons.
Conditions
Tocilizumab
Thyroid Associated Ophthalmopathy
Interventions
DRUG:
Tocilizumab
Sponsor
Sun Yat-sen University